drugset
drugset / Trial / NCT02908438

Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles

NCT02908438 ↗

Phase 1 Unknown 400 enrolled Northwest Women's and Children's Hospital, Xi'an, Shaanxi
RandomizedParallel-groupOpen-labelTreatment

Summary

The study was designed to investigate the effect of luteal-phase administration of gonadotrophin releasing hormone agonist(GnRHa) on pregnancy outcomes in in-vitro fertilization-embryo transfer.

Timeline

Start
2016-09
Primary completion
2017-09
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Decapeptyl Unknown 0.1 mg Subcutaneous

Indications

No indication recorded.